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We previously reported the case of a 64-year-old man with mediastinitis caused by Staphy-
lococcus aureus in which the infecting bacterium acquired linezolid resistance after only 14
days treatment with linezolid. We therefore investigated relevant clinical isolates for possi-
ble mechanisms of this rapid acquisition of linezolid resistance.
Methods
Using clinical S. aureus isolates, we assessed the in vitro mutation rate and performed step-
wise selection for linezolid resistance. To investigate homologous recombination, sequences
were determined for each of the 23S ribosomal RNA (23S rRNA) loci; analyzed sequences
spanned the entirety of each 23S rRNA gene, including domain V, as well as the 16S-23S
intergenic spacer regions. We additionally performed next-generation sequencing on clinical
strains to identify single-nucleotide polymorphisms compared to the N315 genome.
Results
Strains isolated from the patient prior to linezolid exposure (M5-M7) showed higher-level
linezolid resistance than N315, and the pre-exposure strain (M2) exhibited more rapid
acquisition of linezolid resistance than did N315. However, the mutation rates of these and
contemporaneous clinical isolates were similar to those of N315, and the isolates did not
exhibit any mutations in hypermutation-related genes. Sequences of the 23S rRNA genes
and 16S-23S intergenic spacer regions were identical among the pre- and post-exposure
clinical strains. Notably, all of the pre-exposure isolates harbored a recQmissense mutation
(Glu69Asp) with respect to N315; such a lesion may have affected short sequence
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Conclusions
Hypermutation and homologous recombination of the ribosomal RNA genes, including 23S
rRNA genes, appear not to have been sources of the accelerated acquisition of linezolid
resistance observed in our clinical case. Increased frequency of short sequence recombina-
tion may have resulted from a recQ variant in the infecting organism.
Introduction
Linezolid (LZD) is the first approved antibiotic of the oxazolidinone class. This agent is effec-
tive for the treatment of infectious diseases caused by Gram-positive bacteria, including methi-
cillin-resistant Staphylococcus aureus (MRSA). LZD inhibits protein synthesis by binding to
domain V of the 23S rRNA, thereby preventing the formation of the functional 70S initiation
complex required for the bacterial translation process [1]. Reported mechanisms of LZD resis-
tance include point mutation of domain V of the 23S rRNA gene [2], mutation of the ribo-
somal proteins close to the linezolid binding site in the ribosomal peptidyl transferase center
[3], and acquisition of cfr, which encodes a 23S rRNA methylase [4]. However, the clinical
occurrence of LZD resistance is rare, and has been observed only following prolonged exposure
to the drug [5]. This observation is consistent with the low frequency of in vitro mutation,
reported as less than 8 × 10−11 [6]. Recently, we reported consecutive LZD-resistant S. aureus
(LRSA) strains isolated from a patient’s blood cultures after only 2 weeks of LZD treatment [7].
The minimum inhibitory concentration (MIC) of LZD following exposure was 32 μg/ml, com-
pared to an MIC of 4 μg/ml in the parent strain. These LRSA strains harbored a G2576T muta-
tion in multiple 23S rRNA loci. While we could not explain the rapid acquisition of LZD
resistance by these strains, the effect is reminiscent of a hypermutator phenotype. Hypermuta-
tor bacteria exhibit high frequencies of point mutations, often through the inactivation of mis-
match repair genes, resulting in the rapid acquisition of antimicrobial resistance [8]. Separate
work has suggested a role for homologous recombination in the spread of domain V mutations
among the multiple copies of the 23S rRNA genes in a given genome [9, 10], although this pro-
posed mechanism was not demonstrated directly. In the present study, we attempted to eluci-
date the mechanism(s) of the rapid acquisition of LZD resistance in our clinical isolates of S.
aureus.
Materials and Methods
Bacterial strains and culture condition
All clinical strains are listed in Table 1. Four MRSA or LRSA strains (designated M2, M5, M6,
and M7) were consecutively isolated from the same patient before and after use of LZD [7]. M6
is a small colony variant (SCV) that exhibited hemin auxotrophy [7]. Other clinical isolates
(M3, M4, M30, M32, and M13) were obtained as described in Table 1. Each strain was subcul-
tured on TSA with 5% sheep blood (Kohjin Bio Co. Ltd., Saitama, Japan) at 37°C for 24 hours.
Mu3, Mu50, and N315 complete genome data were obtained from GenBank as accession num-
bers AP009324, BA000017.4, and BA000018, respectively.
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Antimicrobial susceptibility test
The MICs were determined by the agar plate dilution method; the interpretation of these
results was performed in accordance with Clinical Laboratory Standards [11].
Stepwise LZD resistance selection assay
Individual colonies of M2, M3, M13, and N315 were resuspended in sterile saline at 0.5 McFar-
land standard and 10 μl of each suspension was inoculated in 1 ml brain heart infusion (BHI)
broth (Nippon Beckton-Dickinson, Fukushima, Japan) containing LZD at concentrations of 0,
0.5, 1, 2, 4, 8, 16, 32, or 64 μg/ml. All cultures were incubated at 37°C for 24 hours with vigorous
shaking (200 rpm/min). For each strain, an aliquot (10 μl) of the culture with the maximum
LZD concentration that still showed visible turbidity was inoculated into fresh BHI broth con-
taining LZD as described above. This consecutive stepwise LZD resistance selection test was
continued for a total of up to 32 passages. The resulting strains are designated using the format
parent strain/resulting MIC/passage number.
At each MIC determination step, 1 loopful (approximately 1 μl) of culture from the well at
1/2 MIC was streaked to TSA with 5% sheep blood and incubated at 37°C for 24 hours. The
resulting isolated colonies were used for PCR to generate templates for sequencing of the 23S
rRNA (domain V) and 16S-23S IGS (intergenic spacer) regions.
Doubling time
Test strains were incubated in BHI broth at 37°C for 20 hours; the resulting cultures were
diluted to an optical density (OD) (at 578 nm) of 0.3 using BHI broth. An aliquot (100 μl) of
each dilution was used to inoculate 10 ml BHI broth in a test tube, and the resulting cultures
were grown using a TVS120MB (ADVANTEC, Tokyo, Japan) at 37°C with shaking at 25 rpm;
the OD (at 600 nm) of each culture was measured automatically every 2 minutes for up to 249
hours. The resulting values were fitted to log approximate equations calculated as y = a  log x
+ b, where x = OD and y = time. The doubling times in the logarithmic growth phase were
Table 1. List of strains used.
Strain References Comments State MICa (μg/ml) of MLSTb PFGEc
No. of infection VAN GEN ABK TET CHL RIF LZD Type
M2 7 Case 1, before use of LZD Infection 1 >32 4 1 8 0.03 4 ST5 A1
M5 7 Case1, after use of LZD Infection 1 >32 8 1 32 0.03 32 ST5 A1
M6 7 Case1, after use of LZD, SCV Infection 1 >32 8 1 32 0.03 32 ST5 A1
M7 7 Case1, after use of LZD Infection 1 >32 2 1 32 0.03 32 NDd A1
M3 7 Case 3 Infection 1 >32 4 1 8 0.03 4 ST5 A1
M4 7 Case 4 Infection 1 >32 1 1 8 0.03 4 ST5 A1
M30 7 Case 7 Carriage 0.5 >32 1 1 8 0.03 4 NDd A1
M32 7 Case 8 Carriage 1 >32 2 1 8 0.03 4 NDd A1
M13 7 Case 14 Carriage 2 <1 1 >16 8 0.03 2 NDd C1
N315 7 HA-MRSA prototype NDd NDd NDd NDd 8 0.03 2 ST5 NDd
aVAN, Vancomycin; GEN, Gentamicin; ABK, Arbekacin; TET, Tetracycline; CHL, Chloramphenicol; RIF, Rifampicin; LZD, Linezolid
bMLST: Multi Locus Sequence Typing
cPFGE: pulsed-field gel electrophoresis
dND: Not done
doi:10.1371/journal.pone.0155512.t001
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calculated as follows: doubling time = (b + a  log OD at t2)–(b + a  log OD at t1) = a  (log
OD at t2—log OD at t1), where OD at t2 = 2  OD at t1.
Mutation rate
Individual colonies of test strains were resuspended in sterile saline at 0.5 McFarland. Ali-
quots (10 μl/inoculum) of these suspensions were used to inoculate 10 tubes containing 1 ml
BHI broth each (small culture system) or 1 tube containing 2 ml BHI broth (big culture sys-
tem). The resulting cultures were incubated at 37°C for 24 hours with shaking. For the small
culture system, 100 μl aliquots of each of the 10 cultures were plated onto separate BHI agar
(Nippon Beckton-Dickinson) plates containing 128x MIC of rifampin; for the large culture
system, 100 μl aliquots of the culture were plated onto 10 separate BHI agar plates contain-
ing 128x MIC of rifampin. To determine the total number of colony forming units (CFUs),
each culture was subjected to 10 fold serial dilutions, and 10 μl aliquots of each dilution were
plated to BHI agar plates. After a 24-hour incubation at 37°C, the colonies were counted and
mutation rate was calculated based on the Ma-Sandri-Sarkar Maximum Likelihood Estima-
tor (MSS-MLE) method (Fluctuation AnaLysis CalculatOR, http://www.keshavsingh.org/
protocols/FALCOR.html) [12]. Hypermutators were defined as strains that exhibited muta-
tion rates at least 10 fold higher than those of control strains.
DNA extraction
Individual colonies were resuspended in 100 μl Tris-EDTA (TE) buffer with 40 U of achro-
mopeptidase (Wako Chemical, Kyoto, Japan). The suspensions were incubated 55°C for 15
minutes and then centrifuged at 20,000 x g at 4°C for 5 minutes, and the resulting superna-
tants were used for PCR amplification and sequencing of genomic DNA. For next-genera-
tion sequencing using the HiSeq2000 (Illumina, Inc., USA), cell lysates were processed using
QIAprep Spin Miniprep Kits (QIAGEN, Germany) according to the manufacturer’s
recommendations.
23S rRNA and 16S-26S intergenic spacer region sequencing
Each copy of 23S rRNA (rrn1—rrn5) gene was amplified using long PCR. The primer pairs
were as previously described by Meka et al. [5]. PrimeSTAR GXL DNA Polymerase (Takara
Bio Inc., Japan) was used for long PCR, and PCR conditions were as follows; denaturation
at 95°C for 1 min; 32 PCR cycles consisting of denaturation at 94°C for 30 sec, annealing at
55°C for 30 sec, and extension at 68°C for 7 min; and final extension at 68°C for 10 min.
PCR products were confirmed by 1% agarose gel electrophoresis. Table 2 shows the
sequences of the primers used for sequencing of the full-length 23S rRNA genes; these
primers were designed using the published genome for S. aureus N315 (GenBank accession
no. NC_002745). For sequencing PCR of the domain V region of the 23S rRNA genes, we
used 2 primers as previously published (GenBank accession no. X68425) [13]. For 16S-23S
intergenic spacer (IGS) region sequencing, primers were as shown in Table 2. Sequencing
reactions using BigDye Terminator v3.1 (Applied Biosystems, Life Technologies, Inc.) were
performed as follows: preincubation at 95°C for 1 min; 32 cycles of denaturation at 94°C for
30 sec, annealing at 55°C for 30 sec, and extension at 72°C for 1 min; and final extension at
72°C for 3 min. The resulting products were analyzed on a 3730 DNA Analyzer (Applied
Biosystems, Life Technologies, Inc.). Determination of 16S-23S IGS region typing was per-
formed as previously reported [14].
Rapidly Acquired Linezolid Resistance in MRSA
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M2 genome analysis and single-nucleotide polymorphism (SNP)
phylogenetic tree
Shotgun sequencing of the M2 chromosomal DNA was performed using Illumina HiSeq 2000
(single reads) and Roche 454 (8-kb paired-end library). All reads were incorporated into a
hybrid assembly using Newbler v2.6. Scaffolds were scanned for open reading frames (ORFs)
and annotated using RAST [15] and BLAST [16].
The resulting M2 chromosome scaffold was compared to the published ST5 S. aureus refer-
ence complete genomes (N315, Mu3, Mu50) using snpTree-1.1 [17] to construct a SNP phylo-
genetic tree. We compared the M2 and N315 genomes for homologs using BlastP bidirectional
best hit analysis with an identity threshold of 60% and an E-value threshold of 1E-08.
SNP detection
We performed single-read sequencing analysis of six of our clinical strains (M2, M3, M5, M6,
M7, M13) using HiSeq 2000 (Illumina, Inc., USA) and mapping based on the N315 genome
(GenBank accession no. NC_002745) [18]; SNP lists were assembled using Genome Traveler
(In Silico Biology, Inc., Mishima, Japan). We especially noted SNPs in hypermutation-related
genes, focusing on previously reported loci [19, 20, 21, 22, 23, 24, 25, 26, 27, 28].
Results
Antimicrobial susceptibility test
The RIF MICs of all the tested strains (M2, M3, M4, M5, M6, M7, M13, M30, M32, N315)
were 0.03 μg/ml.
Stepwise LZD resistance selection test
The results of stepwise LZD resistance selection tests are shown in Fig 1. Elevation of MIC was
defined as hold of increased MIC at two or more consecutive passage. The MICs of LZD
against M2 and M3 exceeded 32 μg/ml within 13 passages, while MICs continued to vary,
Table 2. Primers used in this study.
Name Target Use Sequence
rrn- Fw1 23S rRNA gene Sequencing 5’-TTCGAAAGAACACTCACAAG-3’
rrn- Fw2 23S rRNA gene Sequencing 5’-GGACGACATTAGACGAATCATCTGG-3’
rrn- Fw3 23S rRNA gene Sequencing 5’-GTGAGCGGATGAACTGAGG-3’
rrn- Fw4 23S rRNA gene Sequencing 5’-GCGTTGAAGCATGATCGTAAG-3’
rrn- Fw5 23S rRNA gene Sequencing 5’-CTCGTTAAGGAACTCGGCA-3’
rrn- Fw6 23S rRNA gene Sequencing 5’-TCGGCACAGCTTGTACAGG-3’
rrn- Fw7 23S rRNA gene Sequencing 5’-ATCCTGGGGCTGTAGTCGG-3’
rrn-Rv1 23S rRNA gene Sequencing 5’-GACAACATTTTCGACTACAGG-3’
rrn-Rv2 23S rRNA gene Sequencing 5’-GAGAACCAGCTATCTCCAGG-3’
rrn-Rv3 23S rRNA gene Sequencing 5’-GTCTTTCGCTACTCACACCGGC-3’
rrn-Rv4 23S rRNA gene Sequencing 5’-GGCCTATTCACTGCGGCTC-3’
rrn-Rv5 23S rRNA gene Sequencing 5’-CCACGTAAGCTAGCGCTCACG-3’
rrn-Rv6 23S rRNA gene Sequencing 5’-CTGTCTCACGACGTTCTGAA-3’
rrn-Rv7 23S rRNA gene Sequencing 5’-CCTTGCTATAGTCACCAGAC-3’
IGS-F 16S-23S IGS region Sequencing 5’-AGGAGCTAGCCGTCGAAGGT-3’
IGS-R 16S-23S IGS region Sequencing 5’-AGCTGTAAGTAAGCTTTGATC-3’
doi:10.1371/journal.pone.0155512.t002
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values did not subsequently decrease more than 2-fold during passaging before finally reaching
128 μg/ml. In contrast, increases of the LZDMIC in strains M13 and N315 were relatively
slow, peaking at 16 μg/ml after 12 passages and not rising higher even during long-term (over
30 times) passaging.
Doubling time and mutation rate
Results of doubling time assays are shown in Table 3. N315 had the fastest doubling time; M6
had the slowest doubling time. Doubling times of the LRSA strains tended to be longer than
those of the MRSA strains.
In the only big culture assay performed, M6 (SCV hemin auxotroph) had a significantly
higher mutation rate than those of all the other strains, except for M5 (Table 3). However,
none of the strains fulfilled the definition of hypermutator status.
Fig 1. Stepwise selection of LZD-resistant mutants of MRSA strains. Strains M2 and M3 achieved MICs
over 32 μg/ml in the short term, and reached 128 μg/ml by the end of the study. Strains M13 and N315 were
used as controls in this experiment; neither strains achievedMICs of 32 μg/ml for two consecutive passages.
doi:10.1371/journal.pone.0155512.g001
Table 3. Mutation rate and doubling time of strains used.
Strain Mutation rate (X 10−8 CFU/ml) in
small culture system
Mutation rate (X 10−8 CFU/ml) in big
culture system
Doubling Time
No. Estimated 95% confidence interval Estimated 95% confidence interval Log Approximate Equation** Doubling Time
lower-upper bound lower-upper bound (minites)
M2 1.409 0.926–1.963 5.419 3.544–7.576 y = 38.938ln(x) + 247.48, R² = 0.9963 27
M5 2.008 1.391–2.705 7.884 5.129–11.056 y = 41.943ln(x) + 277.1, R² = 0.995 29.1
M6 1.45 0.964–2.006 14.453 10.455–18.912 y = 45.37ln(x) + 297.94, R² = 0.9977 31.4
M7 1.145 0.782–1.557 4.158 2.738–5.788 y = 43.382ln(x) + 290.73, R² = 0.9948 30.1
M3 0.802 0.49–1.167 4.542 3.13–6.139 y = 39.065ln(x) + 248.48, R² = 0.996 27.1
M4 1.559 1.037–2.157 2.36 1.434–3.446 y = 42.974ln(x) + 247.79, R² = 0.995 29.8
M30 1.307 0.899–1.769 1.552 0.937–2.276 y = 40.621ln(x) + 242.4, R² = 0.9974 28.2
M32 1.373 0.932–1.873 2.548 1.632–3.608 y = 37.004ln(x) + 252.56, R² = 0.9973 25.6
M13 0.596 0.372–0.857 1.526 1.025–2.099 ND* ND*
N315 2.287 1.494–3.198 4.432 2.827–6.29 y = 32.128ln(x) + 221.05, R² = 0.9985 22.3
*ND; not done
** ln: natural logarithm, x: optical density, R²: coefficient determination
doi:10.1371/journal.pone.0155512.t003
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Intrachromosomal variations of 23S rRNA genes and characteristics of
parent strains and isogenic mutants isolated from stepwise LZD
resistance selection tests
Staphylococcus aureus have 5 or 6 copies of 23S rRNA genes with several intrachromosomal
sequence variations (Table 4). Sequencing revealed that M2 and M3 harbored 3 SNPs in 1 copy
of the 23S rRNA genes; the remaining 4 rrn loci in each genome had sequences identical to
each other and to those of the reference genome. Specifically, rrn2 carried C280A, C441T, and
T1584A substitutions (all S. aureus numbering) compared to the reference genome. The rrn
sequences of strain M2/128/15 (parent strain/MIC/passage number, i.e., a strain derived from
M2 after 15 passages with LZD) were identical to those of the parent, except for the presence
(in all 5 loci) of a G2576T (E. coli numbering) mutation.
Table 5 shows the relationship between the number of copies of the mutated 23S rRNA
domain V gene and the MICs of LZD in strains derived in the stepwise selection. M2/128/15
had a G2576T (E. coli numbering) mutation in all rrn loci, and M3/128/32 had a G2447T (E.
coli numbering) mutation in 3 rrn loci. Among the LZD-resistant mutants selected by stepwise
selection from our clinical strains, the MIC of LZD tended to rise as the number of domain V
mutation copies increased. However, LZD-resistant mutants derived by LZD selection from
M13 or N315 harbored a G2236T (S. aureus numbering) mutation in only 1 of the rrn loci.
Changes of IGS region combinations in parent strains and isogenic LZD-
resistant mutants
Table 6 shows 16S-23S IGS region sequences of the parent strains and the isogenic LZD-resis-
tant mutants isolated during the stepwise LZD resistance selection. M2, M3, and Mu50 had the
Table 4. Intrachromosomal variations of 23S rRNA genes.
Strain Intrachromosomal sequence variatios of 23S rRNA genes at respective positions
48 223 261 280 307 312 428 441 1584 2261 2576
N315 G G C C, A (rrn2)a A A, G (rrn1)a G C T, A(rrn1, 2)a G, A (rrn1)a G
Mu50 G G C C, A (rrn2)a A, G (rrn2)a A, G (rrn3)a G C T, A(rrn1, 2)a G, A (rrn1)a G
M2, M3 G G C C, A (rrn2)a A A G C, T (rrn2)a T, A (rrn2)a G G
M2/128/15b G G C C, A (rrn2)a A A G C, T (rrn2)a T, A (rrn2)a G T (rrn1~5)
a: majority, minority base (minority copy number)
b: parent strain/LZD MIC/passage number (acquiring in step wise test)
doi:10.1371/journal.pone.0155512.t004
Table 5. Relationship of the presence of mutated domain V in the 23S rRNA genes with the level of LZD resistance
Parent strain Domain V mutation in the 23S rRNA gene copies of each LZD-sensitive and -resistant strains at MIC of
LZD
Mutational
(wild type) 4 8 16 32 64 128 site
M2 NDa (6)b rrn1, 4, 5 (7)b rrn1,3,4,5 (10)b rrn1,2,3,4,5 (15)b G2576T
M3 NDa (6)b NDa (8)b NDa (15)b rrn1,4,5 (29)b rrn 3,4,5 (32)b G2447T
M13 rrn1 (6)b rrn1 (8)b rrn1 (32)b G2236T
N315 rrn1 (7)b rrn1 (10)b rrn1 (32)b G2236T
a ND: not detected domain V mutation
b passage
doi:10.1371/journal.pone.0155512.t005
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same sequences for the 16S-23S IGS regions. The IGS sequences at rrn1 to rrn5 were identical
among M2, M3, and their isogenic mutants.
M2 genome analysis and SNP phylogenetic tree
Genomic sequence of M2 yielded 2 separate scaffolds. One scaffold corresponded to the cir-
cular chromosomal genome; the second scaffold corresponded to a circular plasmid. The
scaffolds and annotation results are registered in DDBJ under accession numbers DF830066
(M2 chromosome genome) and DF830067 (M2 plasmid). A SNP phylogenetic tree derived
by comparison to the ST5 strains is shown in Fig 2. N315 is the strain most closely related to
M2.
Genes unique to N315 and M2 are shown in Fig 3. Of the genes unique to M2 or N315, no
genes are involved in DNA replication or repair system.
SNP detection
We screened the sequences of over 20 genes previously reported [26, 27, 28] to contribute to
hypermutation (for example,mutS,mutL, uvrD, and dnaQ). Analysis of the genomes of M2,
M3, M5, M6, M7, and M13 revealed that none of these loci exhibited sequence variation com-
pared to N315. However, in screening other loci known to be involved in DNA replication and
repair, we found that only the recQ genes of M2, M3, M5, M6, and M7 (but not that of M13)
harbored a missense mutation (Glu69Asp) compared to the reference genome, indicating that
recQ is involved in DNA replication, repair, and recombination. None of the rpl gene muta-
tions previously implicated in LZD resistance [3, 29] were detected (rplC, rplD, rplV). Strains
M2, M3, M5, M6, and M7 (but not M13) harbored SNPs (compared to the reference genome)
in rplA (which encodes ribosomal protein L1) and rplR (which encodes ribosomal protein
L18). However, the L1 and L18 proteins are located far from the known linezolid-binding posi-
tion [30, 31]; we therefore infer that these variants do not play a role in LZD resistance. Non-
sense mutation of hemH (a T-to-A substitution at base 7 of the ORF, creating a premature
termination codon) appeared responsible for the SCV and hemin auxotrophy phenotypes of
M6 [32].
Table 6. Pattern of 16S-23S IGS regions in parental strains and isogenic linezolid (LZD)-resistant mutants.
Strain Type of 16S-23S IGS
rrn1 rrn2 rrn3 rrn4 rrn5
M2 rrnH rrnJ rrnC rrnE rrnE
M2/32/10a rrnH rrnJ rrnC rrnE rrnE
M2/128/15a rrnH rrnJ rrnC rrnE rrnE
M3 rrnH rrnJ rrnC rrnE rrnE
M3/64/29a rrnH rrnJ rrnC rrnE rrnE
M3/128/32a rrnH rrnJ rrnC rrnE rrnE
N315 rrnC rrnJ rrnC rrnE rrnE
Mu50 rrnH rrnJ rrnC rrnE rrnE
NCTC 8325 rrnH rrnH rrnC A48073 rrnF
MRSA252 rrnY rrnF rrnC rrnH rrnZ
a: wild type/LZD MIC/passage number (acquiring strains in step wise test) described by Tsuru T et al (ref 27).
doi:10.1371/journal.pone.0155512.t006
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Discussion
Known mechanisms of LZD resistance are mutation of a 23S rRNA gene (G2576T, T2500A,
C2461T, or G2447T); cfr or fexA acquisition [33], and mutation of selected rpl loci (rplC, rplD,
or rplV). In a systematic review, the most popular mechanism of linezolid resistance was
G2576T mutation in 40 of 63 (63.5%) LRSA strains [34], as well as those in this study. Interest-
ingly, these our clinical LRSA strains acquired the most frequently detected rrnmutation
(G2576T) in three rrns after only 2 weeks of clinical exposure to LZD, in contrast of acquisition
of LZD resistance after 20 to 48.9 months administration of LZD [34, 35].
First, we focused on hypermutator-related genes such asmut directing mismatch repair sys-
tem. Biser et al. reported that S. aureus SCV strains detected from sputum of cystic fibrosis
Fig 2. Phylogenetic tree of SNPs in the M2 and ST5 (MLST) reference strains.
doi:10.1371/journal.pone.0155512.g002
Fig 3. Venn diagram showing unique genes between N315 and M2 (SA or M2PLR number).
doi:10.1371/journal.pone.0155512.g003
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patients exhibited resistance to GEN, fosfomycin, RIF, ciprofloxacin (CIP), and ERY [22].
Those S. aureus SCV strains harbored frame shift mutations in themutL ormutS loci and
exhibited elevated mutation frequencies. ERY resistance in those strains was due to A2058G
and A2058T mutation in one or more 23S rRNA genes. This phenomenon suggests that hyper-
mutator strains can more readily acquire point mutations in the 23S rRNA genes. Similarly,
Oliver et al. reported that amutS-deleted Pseudomonas aeruginosa exhibited an elevated muta-
tion rate, and that the MIC and the minimum bactericidal concentration (MBC) of imipenem
and CIP rose approximately 10-fold after a 36-hour exposure to these agents [21]. In contrast,
in the present work, the mutation rates of our clinical isolates (both the original LZD-sensitive
strains and the LZD-resistant strains) were similar to those determined for M13 and N315.
However, we cannot define M6 as a hypermutator in our experiment, because the M6 strain
exhibited only a 3-fold elevation in frequency of mutation to RIF resistance when compared to
a reference strain. Additionally, this difference was not reproducible in several other experi-
ments. Mapping of the M2, M3, M5, M6, and M7 genomes to the N315 genome revealed no
other mutations at any previously described hypermutation-related genes.
Second, we considered the potential contribution of intrachromosomal recombination to
LZD resistance. If a single domain V mutation occurs, the lesion could spread among multiple
copies of 23S rRNA genes via intrachromosomal homologous recombination [9, 10]. Indeed,
increases in the number of G2576T-mutated rrn loci correlated with increased LZD resistance
in our strains. However, homologous recombination among mutated 23S rRNA gene copies
has not been demonstrated directly in any articles. Therefore, we focused on 23S rRNA SNPs
and 16S-23S IGS region sequences in our strains, compared with the 23S rRNA gene sequences
published for 4 reference strains. These analyses revealed the presence of several intrachromo-
somal 23S rRNA variations and 16S-23S IGS regions in each ribosomal operon [18, 36, 37, 38].
The 16S-23S IGS regions include tRNA gene sequences and are composed of 13 variable
sequences and 3 conserved sequences (CS). Over 10 distinct combination patterns of 16S-23S
IGS regions have been reported, and have been explained as combinations of upper and lower
variable sequences [14]. The possibility of homologous recombination involving the long
homology of CS1 and CS2 in 16S-23S IGS region has been reported [38]. If homologous
recombination among large fragments containing rrns occurs, intrachromosomal exchanges of
23S rRNA sequences may occur, and 16S-23S IGS regions may be rearranged. Nevertheless, we
did not detect any changes of intrachromosomal 23S rRNA variations or 16S-23S IGS regions
between the parent strains and isogenic mutants characterized in the present study. However,
we could not exclude the occurrence of very short sequence recombinations for regions encom-
passing domain V.
Third, as a result of SNP screening, we detected a missense mutation in the recQ gene (ORF
M2PLR_1323 in our M2 genome sequence). The RecQ protein, which is conserved from bacte-
ria to humans, is involved in the maintenance of genetic integrity; loss of function of the
human RecQ homolog (BLM-helicase) is responsible for several human genetic disorders,
including Bloom syndrome, Werner syndrome, and Rothmund-Thomson syndrome [39].
These diseases are characterized by hyper-recombination, genome rearrangements, and pro-
pensity to the development of cancer [39]. In E. coli, RecQ suppresses illegitimate recombina-
tion [40, 41]. Grierson et al. reported that deficiency for the BLM-helicase (Bloom syndrome
RecQ like helicase) activity increased intrachromosomal recombination of rDNA repeats [42].
If the function of recQ in S. aureus is similar to that in E. coli, recQmutation might increase
intrachromosomal recombination among rrn loci, facilitating the rapid spread of domain V
mutations among rrns after acquisition of the first mutation. Further studies of the biological
role of recQ in S. aureus will be needed.
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23S rRNA gene mutation, rpl SNPs, and nonsense mutation of hemHmay all be causes of
slow growth. The doubling time tends to lengthen with increasing number of these factors. 23S
rRNA is essential for maintaining the fundamental life process because of its role in protein
synthesis. It has been reported that 23S A2503U, U2504G, G2505A, and G2576U mutations
result in increased doubling times inMycobacterium smegmatis [43, 44], with the G2576U
mutation resulting in 3-fold slower growth [45]. Mutations in the rplD and rplV genes also
have been shown to reduce growth rates [45, 46]. Although no mutations in rplC, rplD, or rplV
were detected in our strains, rplA rplRmutations detected may affect slow growth rates. In the
context of the present work, we hypothesize that these mutations may allow rapid selection of
LZD-resistant mutants by permitting bacteria to slow protein synthesis and thereby escape
LZD’s action.
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